根据提供的文档内容，该文档不包含任何与公司或行业相关的实质性信息 文档内容仅为一条技术性提示 要求用户启用浏览器中的Javascript和cookies 并可能需禁用广告拦截器以继续操作 [1]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Dropbox (DBX) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +15.63%. A quarter ago, it was expected that this online file-sharing company would post earnings of $0.63 per share when it actually produced earnings of $0.71, delivering a surprise of +12.7%.Over the last four quarters, t ...

EOG Resources (EOG) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.52%. A quarter ago, it was expected that this oil and gas company would post earnings of $2.21 per share when it actually produced earnings of $2.32, delivering a surprise of +4.98%.Over the last four quarters, th ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

DNY59/E+ via Getty Images Pardon the mixed metaphor, but I couldn’t resist. Jamie Dimon, Chairman and Chief Executive Officer of JP Morgan Chase, whose comments are always insightful and direct, said the following last month with regard to the bankruptcy filings from First Brands, an auto parts supplier, and Tricolor, a seller of and subprime lender against used cars: “My antenna goes up when things like that happen. And I probably shouldn’t say this, but when you see one cockroach, there are probably m ...

CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the presentation of a post-hoc win odds analysis of all-cause mortality and hospitalization from the Phase 3 INNO2VATE trials of vadadustat at the American Society of Nephrology Kidney Week 2025 (ASN Kidney Week). The presentation entitled, “Win-Odds Analysis of Deaths and Hospitalization in Patie ...

Contacts For media and/or investor relations please contact: IR@Anaergia.com Industry: Nov 6, 2025 6:30 PM Eastern Standard Time Anaergia Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call Share BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. ("Anaergia†or the "Company") (TSX: ANRG) (OTCQX: ANRGF) will hold a conference call on Wednesday, November 12, 2025, at 10:00 a.m. ET, during which Chief Executive Officer Assaf Onn, Chief Financial Officer Greg Wolf, and Chief Operating Officer ...

Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² Tegoprubart demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus Supports advancement into Phase 3 development as a potential new standard for the prevention of kidney transplant rejection Conference call ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...